Omnicell (OMCL) Tops Q1 EPS by 33c; offers guidance

Omnicell (NASDAQ: OMCL) reported Q1 EPS of $0.39, $0.33 better than the analyst estimate of $0.06. Revenue for the quarter came in at $291 million versus the consensus estimate of $277.65 million.

GUIDANCE:

Omnicell sees Q2 2023 EPS of $0.25-$0.35, versus the consensus of $0.37. Omnicell sees Q2 2023 revenue of $278-288 million, versus the consensus of $288.65 million.

Omnicell sees FY2023 EPS of $1.55-$1.80, versus the consensus of $1.63. Omnicell sees FY2023 revenue of $1.15-1.19 billion, versus the consensus of $1.17 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Aytu BioScience (AYTU) Tops Q4 EPS by 28c
• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion